| Product NDC: | 63323-304 |
| Proprietary Name: | Piperacillin and Tazobactam |
| Non Proprietary Name: | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM |
| Active Ingredient(s): | 36; 4.5 g/1; g/1 & nbsp; PIPERACILLIN SODIUM,TAZOBACTAM SODIUM |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63323-304 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090498 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110531 |
| Package NDC: | 63323-304-74 |
| Package Description: | 1 INJECTION, POWDER, FOR SOLUTION in 1 BOX (63323-304-74) |
| NDC Code | 63323-304-74 |
| Proprietary Name | Piperacillin and Tazobactam |
| Package Description | 1 INJECTION, POWDER, FOR SOLUTION in 1 BOX (63323-304-74) |
| Product NDC | 63323-304 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110531 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
| Strength Number | 36; 4.5 |
| Strength Unit | g/1; g/1 |
| Pharmaceutical Classes | beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |